Immutep Limited (IMMP)
NASDAQ: IMMP · Real-Time Price · USD
1.640
-0.020 (-1.20%)
At close: Sep 12, 2025, 4:00 PM EDT
1.670
+0.030 (1.83%)
After-hours: Sep 12, 2025, 6:58 PM EDT
Immutep Market Cap
Immutep has a market cap or net worth of $224.01 million as of September 12, 2025. Its market cap has decreased by -21.15% in one year.
Market Cap
224.01M
Enterprise Value
139.04M
1-Year Change
-21.15%
Ranking
Category
Stock Price
$1.64
Market Cap Chart
Since April 19, 2012, Immutep's market cap has increased from $74.60M to $224.01M, an increase of 200.28%. That is a compound annual growth rate of 8.55%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 12, 2025 | 238.70M | -24.27% |
Dec 31, 2024 | 315.20M | 10.60% |
Dec 29, 2023 | 285.00M | 87.99% |
Dec 30, 2022 | 151.60M | -38.22% |
Dec 31, 2021 | 245.40M | 60.29% |
Dec 31, 2020 | 153.10M | 152.22% |
Dec 31, 2019 | 60.70M | 8.98% |
Dec 31, 2018 | 55.70M | 70.34% |
Dec 29, 2017 | 32.70M | 125.52% |
Dec 30, 2016 | 14.50M | -27.50% |
Dec 31, 2015 | 20.00M | 143.90% |
Dec 31, 2014 | 8.20M | -29.91% |
Dec 31, 2013 | 11.70M | -68.03% |
Dec 31, 2012 | 36.60M | -50.94% |
Apr 19, 2012 | 74.60M | - |
View and export this data all the way back to 2012. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 678.14B |
Johnson & Johnson | 428.83B |
AbbVie | 385.71B |
UnitedHealth Group | 319.26B |
AstraZeneca | 247.84B |
Novo Nordisk | 242.99B |
Novartis AG | 240.09B |
Abbott Laboratories | 232.75B |